ASCENDIS PHARMA A/S shareholders Q3 2023

ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 164 filers reported holding ASCENDIS PHARMA A/S in Q3 2023. The put-call ratio across all filers is 1.12 and the average weighting 0.6%.

ASCENDIS PHARMA A/S shareholders Q3 2023
NameSharesValueWeighting ↓
BROWN ADVISORY INC 510,109$47,766,6470.08%
SECTORAL ASSET MANAGEMENT INC 4,241$397,1270.08%
Alyeska Investment Group, L.P. 112,994$10,580,7580.07%
SEI INVESTMENTS CO 396,440$37,122,6520.07%
WELLINGTON MANAGEMENT GROUP LLP 3,277,172$306,874,3860.06%
FRANKLIN RESOURCES INC 1,213,285$113,612,0480.06%
Capital International Investors 2,168,443$203,053,0030.05%
Avior Wealth Management, LLC 7,177$672,0540.04%
PRELUDE CAPITAL MANAGEMENT, LLC 7,200$674,2080.04%
FMR LLC 5,136,282$480,961,4470.04%
Chicago Partners Investment Group LLC 8,850$771,1890.04%
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 1,264,470$118,404,9710.04%
China Universal Asset Management Co., Ltd. 1,462$1370.04%
Gilbert & Cook, Inc. 2,618$245,1500.04%
XTX Topco Ltd 2,398$224,5490.04%
Hennion & Walsh Asset Management, Inc. 6,238$584,1260.04%
Caption Management, LLC 26,000$2,434,6400.04%
Allspring Global Investments Holdings, LLC 212,995$19,944,9930.04%
Bayesian Capital Management, LP 3,129$293,0000.03%
Gratus Capital, LLC 5,000$468,2000.03%
External links

This page lists ASCENDIS PHARMA A/S's shareholders in Q3 2023. To view ASCENDIS PHARMA A/S's shareholder history, click here.